What is the recommended dosing regimen for amikacin (an aminoglycoside antibiotic)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 23, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Amikacin Dosing Recommendations

The recommended dosing regimen for amikacin in adults with normal renal function is 15 mg/kg/day, administered either as a single daily dose or divided into 2-3 doses at equally-divided intervals. 1

Adult Dosing

Normal Renal Function

  • Single daily dosing: 15 mg/kg once daily (preferred approach)
  • Divided dosing: 7.5 mg/kg every 12 hours or 5 mg/kg every 8 hours
  • Maximum daily dose: Should not exceed 1.5 grams per day 1

Target Serum Levels

  • Peak concentration:
    • 25-35 mg/kg for daily dosing
    • 65-80 mg/kg for three times weekly dosing 2
  • Trough concentration: <5 mg/kg (critical to avoid toxicity) 2, 3
  • Timing of samples:
    • Trough: Just before next dose
    • Peak: 90-120 minutes after infusion ends 2

Impaired Renal Function

Two approaches are recommended:

  1. Normal dose at prolonged intervals:

    • Calculate interval (hours) = patient's serum creatinine × 9
    • Example: If serum creatinine is 2 mg/dL, administer 7.5 mg/kg every 18 hours 1
  2. Reduced dose at fixed intervals:

    • Dosing should be adjusted based on creatinine clearance
    • Serum amikacin concentrations should be monitored 1

Pediatric Dosing

Normal Renal Function

  • Infants and children: 15-22.5 mg/kg/day divided every 8 hours 2
  • Higher doses: Some experts recommend initial doses of 30 mg/kg/day divided every 8 hours in specific conditions (cystic fibrosis, febrile neutropenia) 2

Neonatal Dosing

Based on weight and postnatal age:

  • <1200g, 0-4 weeks: 7.5 mg/kg every 18-24 hours
  • 1200-2000g, ≤7 days: 7.5 mg/kg every 12 hours
  • >2000g, ≤7 days: 7.5-10 mg/kg every 12 hours
  • <1200g, >7 days: 7.5-10 mg/kg every 8-12 hours
  • >2000g, >7 days: 10 mg/kg every 8 hours 2

Special Indications

Complicated Urinary Tract Infections

  • Standard dose: 15 mg/kg/day IV once daily 2
  • Alternative: For uncomplicated UTIs, 250 mg twice daily may be used 1

Non-tuberculous Mycobacterial Pulmonary Disease

  • Daily dosing: 15 mg/kg once daily
  • Three times weekly dosing: 15-25 mg/kg three times per week 2

Monitoring Recommendations

Frequency of Monitoring

  • Serum levels:
    • Peak level in first week, repeat if poor response
    • Trough levels weekly for first 4 weeks, then fortnightly when stable 2, 3
  • Renal function: Twice weekly during first month, then monthly 3
  • Auditory function: Regular audiometric testing 3

Adjustments Based on Levels

  • High trough level: Extend dosing interval
  • High peak level: Reduce dose
  • Low peak level: Increase dose 2

Important Considerations

Administration

  • Dilute in 100-200 mL of compatible solution
  • Administer over 30-60 minutes (longer for infants) 3

Safety Concerns

  • Nephrotoxicity: More common with prolonged treatment, higher doses, concurrent diuretics, advanced age, and pre-existing renal insufficiency 3
  • Ototoxicity: Irreversible vestibulocochlear nerve damage can occur 2
  • Endocrine effects: Hypocalcemia, hypomagnesemia, and hypokalemia 2

Evidence for Once-Daily Dosing

Recent research supports once-daily dosing as it:

  • Provides higher peak concentrations for better bactericidal activity
  • Results in higher clinical cure rates (83% vs 66% for twice-daily dosing) 4
  • Demonstrates lower nephrotoxicity (21% vs 35% for twice-daily dosing) 4

For severe sepsis or septic shock, higher loading doses (≥25 mg/kg) may be needed due to increased volume of distribution, though standard maintenance doses are typically sufficient afterward 5.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Amikacin Therapy

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.